Final answer:
Patients who have experienced cardiac arrest and are at risk for bleeding complications should be targeted to the higher end of the TTM range, closer to 36C to minimize the risk of bleeding while benefiting from TTM.
Step-by-step explanation:
The question at hand is regarding therapeutic hypothermia, also known as targeted temperature management (TTM), which is used in certain medical conditions to improve outcomes. Specifically, patients who have experienced a cardiac arrest and have achieved return of spontaneous circulation (ROSC) but remain unconscious are often subjected to TTM. During this process, the body temperature is maintained at a controlled range. A patient undergoing TTM who should be targeted to the higher end of the temperature range would generally be someone at risk for adverse events associated with lower temperatures, such as an individual with a preexisting coagulopathy or a significant risk of bleeding. In these cases, maintaining the temperature closer to 36 degrees Celsius can help minimize the risk of bleeding while still providing the neuroprotective effects of mild hypothermia.